COVID-19 and diabetes: the contributions of hyperglycemia.

Wang, Jing; Meng, Wen

Wang, Jing; Meng, Wen.

Wang J; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China.
Meng W; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China.

J Mol Cell Biol ; 12(12): 958-962, 2020 09 07.

Article in English | MEDLINE | ID: covidwho-811285

Subject(s)

COVID-19/complications; Diabetes Complications; Hyperglycemia/complications; SARS-CoV-2; Angiotensin-Converting Enzyme 2/metabolism; Blood Glucose/metabolism; COVID-19/pathology; COVID-19/physiopathology; Cytokine Release Syndrome/etiology; Cytokine Release Syndrome/immunology; Cytokine Release Syndrome/metabolism; Diabetes Complications/pathology; Diabetes Complications/physiopathology; Glycated Hemoglobin/metabolism; Humans; Hyperglycemia/pathology; Hyperglycemia/physiopathology; Immune Tolerance; Inflammation/etiology; Inflammation/immunology; Lactic Acid/metabolism; Lung/pathology; Lung/physiopathology; Models, Biological; Pandemics; Prognosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Complications / SARS-CoV-2 / COVID-19 / Hyperglycemia Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Mol Cell Biol Journal subject: Molecular Biology Year: 2020 Document Type: Article Affiliation country: Jmcb

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google